AC Immune (ACIU) Q2 2026 Earnings — Beat Estimates

Screener

Reported August 5, 2026 · Before market open

Revenue$9.8MBeat by $245.5K

EPS$0.03Beat by $0.13

Revenue estimate$9.6M

EPS estimate-$0.10

Next report

Nov 3, 2026 (in 3 months)

Revenue estimate$249.7K

EPS estimate-$0.22

Versus estimates

Revenue

Q2 2026$9.8MBeat by $245.5K

Q1 2026$1.4MBeat by $1.1M Q4 2025$426.4KMiss by $1.0M Q3 2025$1.2MBeat by $36.9K Q2 2025$1.6MBeat by $1.3M Q1 2025$1.2MBeat by $688.8K

Diluted EPS

Q2 2026$0.03Beat by $0.13

Q1 2026-$0.19Beat by $0.01 Q4 2025-$0.18Beat by $0.01 Q3 2025-$0.20Beat by $0.02 Q2 2025-$0.25Miss by $0.05 Q1 2025-$0.21Beat by $0.01

FAQ

When did AC Immune report Q2 2026 earnings?: AC Immune (ACIU) reported Q2 2026 earnings on August 5, 2026 before market open.
What were AC Immune's Q2 2026 revenue and EPS?: AC Immune reported revenue of $9.8M and eps of $0.03 for Q2 2026.
Did AC Immune beat estimates in Q2 2026?: Revenue beat the consensus estimate of $9.6M by $245.5K. EPS beat the consensus estimate of $-0.10 by $0.13.
How did AC Immune's Q2 2026 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 498.6% from $1.6M a year earlier.

Ask the moment AC Immune reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk